Dihexa Research Peptide Protocols: Reconstitution & Storage The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. Announces Peptide Availability Through Licensed Pharmacies Gabriel Alizaidy, MD, MS posted on the topic LinkedIn An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica